Skip to main content

01.03.2016 | Gynecologic Cancers (NS Reed, Section Editor)

Can We Be Less Radical with Surgery for Early Cervical Cancer?

verfasst von: Madeleine C. Macdonald, John A. Tidy

Erschienen in: Current Oncology Reports | Ausgabe 3/2016

Einloggen, um Zugang zu erhalten

Abstract

Although a rare cancer in the developed world due to the success of cervical screening programmes, cervical cancer remains one of the most common cancers diagnosed in women under the age of 35 years old. Radical hysterectomy and more recently radical trachelectomy have been highly effective in curing the majority of women with early stage disease. Many, however, are left with long-term ‘survivorship’ issues including bowel, bladder and sexual dysfunction. In view of these chronic co-morbidities, many clinicians now consider whether a less radical approach to surgery may be an option for some women. This review focuses on the current evidence for the safety of conservative surgery for early stage cervical cancer with regard to cure rates in comparison to standard management, as well as any improvement in short and long-term morbidity associated with a more conservative approach.
Literatur
3.
Zurück zum Zitat Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2012, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2012/, based on November 2014 SEER data submission, posted to the SEER web site, April 2015. Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2012, National Cancer Institute. Bethesda, MD, http://​seer.​cancer.​gov/​csr/​1975_​2012/​, based on November 2014 SEER data submission, posted to the SEER web site, April 2015.
4.
Zurück zum Zitat Abryn M, Castellsague X, de Sanjose S, Bruni L, Saraiya M, Bray F, et al. Worldwide burden of cervical cancer in 2008. Ann Oncol. 2011;22:2675–86.CrossRef Abryn M, Castellsague X, de Sanjose S, Bruni L, Saraiya M, Bray F, et al. Worldwide burden of cervical cancer in 2008. Ann Oncol. 2011;22:2675–86.CrossRef
5.
Zurück zum Zitat Roque DR, Wysham WZ, Soper JT. Surgical management of CC The Surgical Management of Cervical Cancer: an overview and literature. Obstet Gynecol Surv. 2014;69(7):426–41.CrossRefPubMed Roque DR, Wysham WZ, Soper JT. Surgical management of CC The Surgical Management of Cervical Cancer: an overview and literature. Obstet Gynecol Surv. 2014;69(7):426–41.CrossRefPubMed
6.
8.
Zurück zum Zitat Covens A, Rosen B, Murphy J, Laframboise S, DePetrillo AD, Lickrish G, et al. Changes in the demographics and perioperative care of stage IA(2)/IB(1) cervical cancer over the past 16 years. Gynecol Oncol. 2001;81:133–7.CrossRefPubMed Covens A, Rosen B, Murphy J, Laframboise S, DePetrillo AD, Lickrish G, et al. Changes in the demographics and perioperative care of stage IA(2)/IB(1) cervical cancer over the past 16 years. Gynecol Oncol. 2001;81:133–7.CrossRefPubMed
9.••
Zurück zum Zitat Reade CJ, Eiriksson LR, Covens A. Surgery for early stage cervical cancer: how radical should it be? Gynecol Oncol. 2013;131:222–30. Radical surgery for early cervical cancer is associated with significant short and long term morbidities. Less radical management appears to be safe in selected patients.CrossRefPubMed Reade CJ, Eiriksson LR, Covens A. Surgery for early stage cervical cancer: how radical should it be? Gynecol Oncol. 2013;131:222–30. Radical surgery for early cervical cancer is associated with significant short and long term morbidities. Less radical management appears to be safe in selected patients.CrossRefPubMed
11.
Zurück zum Zitat Plante M, Gregoire J, Renaud MC, Roy M. The vaginal radical trachelectomy: an update of a series of 125 cases and 106 pregnancies. Gynecol Oncol. 2011;121:290–7.CrossRefPubMed Plante M, Gregoire J, Renaud MC, Roy M. The vaginal radical trachelectomy: an update of a series of 125 cases and 106 pregnancies. Gynecol Oncol. 2011;121:290–7.CrossRefPubMed
12.
Zurück zum Zitat Wethington SL, Cibula D, Duska LR, Garrett L, Kim CH, Chi DS, et al. An international series on abdominal radical trachelectomy: 101 patients and 28 pregnancies. Int J Gynecol Cancer. 2012;22:1251–7.CrossRefPubMed Wethington SL, Cibula D, Duska LR, Garrett L, Kim CH, Chi DS, et al. An international series on abdominal radical trachelectomy: 101 patients and 28 pregnancies. Int J Gynecol Cancer. 2012;22:1251–7.CrossRefPubMed
14.
Zurück zum Zitat Colombo NS, Carinelli S, Colombo AC, Marini C, Rollo D, Sessa C. Cervical cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2012;23(7):vii27–32.PubMed Colombo NS, Carinelli S, Colombo AC, Marini C, Rollo D, Sessa C. Cervical cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2012;23(7):vii27–32.PubMed
15.
Zurück zum Zitat Malzoni M, Tinelli R, Cosentino F, Fusco A, Malzoni C. Total laparoscopic radical hysterectomy versus abdominal radical hysterectomy with lymphadenectomy in patients with early cervical cancer: our experience. Ann Surg Oncol. 2009;16(5):1316–23.CrossRefPubMed Malzoni M, Tinelli R, Cosentino F, Fusco A, Malzoni C. Total laparoscopic radical hysterectomy versus abdominal radical hysterectomy with lymphadenectomy in patients with early cervical cancer: our experience. Ann Surg Oncol. 2009;16(5):1316–23.CrossRefPubMed
16.
Zurück zum Zitat Raspagliesi F, Ditto A, Fontanelli R, Zanaboni F, Solima E, Spatti G, et al. Type II versus type III nerve-sparing radical hysterectomy: comparison of lower urinary tract dysfunctions. Gynecol Oncol. 2006;102(2):256–62.CrossRefPubMed Raspagliesi F, Ditto A, Fontanelli R, Zanaboni F, Solima E, Spatti G, et al. Type II versus type III nerve-sparing radical hysterectomy: comparison of lower urinary tract dysfunctions. Gynecol Oncol. 2006;102(2):256–62.CrossRefPubMed
17.
Zurück zum Zitat Todo Y, Kuwabara M, Watari H, Ebina Y, Takeda M, Kudo M, et al. Urodynamic study on postsurgical bladder function in cervical cancer treated with systematic nerve-sparing radical hysterectomy. Int J Gynecol Cancer. 2006;16(1):369–75.CrossRefPubMed Todo Y, Kuwabara M, Watari H, Ebina Y, Takeda M, Kudo M, et al. Urodynamic study on postsurgical bladder function in cervical cancer treated with systematic nerve-sparing radical hysterectomy. Int J Gynecol Cancer. 2006;16(1):369–75.CrossRefPubMed
18.
Zurück zum Zitat Froeding LP, Ottosen C, Rung-Hansen H, Svane D, Mosgaard BJ, Jensen PT. Sexual functioning and vaginal changes after radical vaginal trachelectomy in early stage cervical cancer patients: a longitudinal study. J Sex Med. 2014;11:595–604.CrossRefPubMed Froeding LP, Ottosen C, Rung-Hansen H, Svane D, Mosgaard BJ, Jensen PT. Sexual functioning and vaginal changes after radical vaginal trachelectomy in early stage cervical cancer patients: a longitudinal study. J Sex Med. 2014;11:595–604.CrossRefPubMed
19.
Zurück zum Zitat Ramirez PT, Pareja R, Rendon GJ, Millan C, Frumovitz M, Schmeler KM. Management of low-risk early-stage cervical cancer: should conization, simple trachelectomy, or simple hysterectomy replace radical surgery as the new standard of care? Gynecol Oncol. 2014;132(1):254–9.CrossRefPubMedPubMedCentral Ramirez PT, Pareja R, Rendon GJ, Millan C, Frumovitz M, Schmeler KM. Management of low-risk early-stage cervical cancer: should conization, simple trachelectomy, or simple hysterectomy replace radical surgery as the new standard of care? Gynecol Oncol. 2014;132(1):254–9.CrossRefPubMedPubMedCentral
22.
Zurück zum Zitat Landoni F, Maneo A, Zapardiel I, Zanagnolo V, Mangioni C. Class I versus class III radical hysterectomy in stage IBI–IIB cervical cancer. a prospective randomized study. Eur J Surg Oncol. 2012;38:203–9.CrossRefPubMed Landoni F, Maneo A, Zapardiel I, Zanagnolo V, Mangioni C. Class I versus class III radical hysterectomy in stage IBI–IIB cervical cancer. a prospective randomized study. Eur J Surg Oncol. 2012;38:203–9.CrossRefPubMed
23.
Zurück zum Zitat Wright JD, Grigsby PW, Brooks R, Powell MA, Gibb RK, Gao F, et al. Utility of parametrectomy for early stage cervical cancer treated with radical hysterectomy. Cancer. 2007;110(6):1281–6.CrossRefPubMed Wright JD, Grigsby PW, Brooks R, Powell MA, Gibb RK, Gao F, et al. Utility of parametrectomy for early stage cervical cancer treated with radical hysterectomy. Cancer. 2007;110(6):1281–6.CrossRefPubMed
24.
Zurück zum Zitat Frumovitz M, Sun CC, Schmeler KM, Deavers MT, dos Reis R, Levenback CF, et al. Parametrial involvement in radical hysterectomy specimens for women with early-stage cervical cancer. Obstet Gynecol. 2009;114(1):93–9.CrossRefPubMed Frumovitz M, Sun CC, Schmeler KM, Deavers MT, dos Reis R, Levenback CF, et al. Parametrial involvement in radical hysterectomy specimens for women with early-stage cervical cancer. Obstet Gynecol. 2009;114(1):93–9.CrossRefPubMed
25.
Zurück zum Zitat Covens A, Rosen B, Murphy J, Laframboise S, DePetrillo AD, Lickrish G, et al. How important is removal of the parametrium at surgery for carcinoma of the cervix? Gynecol Oncol. 2002;84(1):145–9.CrossRefPubMed Covens A, Rosen B, Murphy J, Laframboise S, DePetrillo AD, Lickrish G, et al. How important is removal of the parametrium at surgery for carcinoma of the cervix? Gynecol Oncol. 2002;84(1):145–9.CrossRefPubMed
26.
Zurück zum Zitat Lee JY, Youm J, Kim JW, Cho JY, Kim MA, Kim TH, et al. Identifying a low-risk group for parametrial involvement in microscopic stage 1B1 cervical cancer using criteria from ongoing studies and a new MRI criterion. BMC Cancer. 2015;15(1):167–73.CrossRefPubMedPubMedCentral Lee JY, Youm J, Kim JW, Cho JY, Kim MA, Kim TH, et al. Identifying a low-risk group for parametrial involvement in microscopic stage 1B1 cervical cancer using criteria from ongoing studies and a new MRI criterion. BMC Cancer. 2015;15(1):167–73.CrossRefPubMedPubMedCentral
27.••
Zurück zum Zitat Plante M. A Randomized Trial comparing Radical Hysterectomy and Pelvic Node Dissection vs Simple Hysterectomy and Pelvic Node Dissection in Patients with Low Risk Early Stage Cervical Cancer. NCIC Clinical Trials Group. NCT016589309.ClinicalTrials.gov The SHAPE Trial; 2013. Radical surgical treatment has been highly effective at curing women of early cervical cancer; however living with the consequences of such surgery has prompted the first randomised control Phase 3 trial to assess survival, morbidity from treatment and quality of life in patients undergoing simple versus radical hysterectomy and pelvic node dissection. Plante M. A Randomized Trial comparing Radical Hysterectomy and Pelvic Node Dissection vs Simple Hysterectomy and Pelvic Node Dissection in Patients with Low Risk Early Stage Cervical Cancer. NCIC Clinical Trials Group. NCT016589309.ClinicalTrials.gov The SHAPE Trial; 2013. Radical surgical treatment has been highly effective at curing women of early cervical cancer; however living with the consequences of such surgery has prompted the first randomised control Phase 3 trial to assess survival, morbidity from treatment and quality of life in patients undergoing simple versus radical hysterectomy and pelvic node dissection.
28.
Zurück zum Zitat Schmeler KM, Frumovitz M, Ramirez PT. Conservative management of early stage cervical cancer:is there a role for less radical surgery? Gynecol Oncol. 2011;120:321–5.CrossRefPubMedPubMedCentral Schmeler KM, Frumovitz M, Ramirez PT. Conservative management of early stage cervical cancer:is there a role for less radical surgery? Gynecol Oncol. 2011;120:321–5.CrossRefPubMedPubMedCentral
30.
Zurück zum Zitat Lecuru F, Mathevet P, Querleu D, LeBlanc E, Morice P, Darai E, et al. Bilateral negative sentinel nodes accurately predict absence of lymph node metastasis in early cervical cancer: results of the SENTICOL study. J Clin Oncol. 2011;29(13):1686–91.CrossRefPubMed Lecuru F, Mathevet P, Querleu D, LeBlanc E, Morice P, Darai E, et al. Bilateral negative sentinel nodes accurately predict absence of lymph node metastasis in early cervical cancer: results of the SENTICOL study. J Clin Oncol. 2011;29(13):1686–91.CrossRefPubMed
31.••
Zurück zum Zitat Bats AS, Frati A, Froissart M, Orliaguet I, Querleu D, Zerdoud S, et al. Feasibility and performance of lymphoscintigraphy in sentinel lymph node biopsy for early cervical cancer: results of the prospective multicentre SENTICOL study. Ann Nucl Med. 2015;29:63–70. Undergoing pelvic lymphadenectomy leaves a woman at risk of chronic lymphoedema. Sentinel node mapping appears to be feasible and safe in women with early stage cervical cancer. Further studies are required to assess if it may be used to reduce pelvic lymph node dissection in selected cases.CrossRefPubMedPubMedCentral Bats AS, Frati A, Froissart M, Orliaguet I, Querleu D, Zerdoud S, et al. Feasibility and performance of lymphoscintigraphy in sentinel lymph node biopsy for early cervical cancer: results of the prospective multicentre SENTICOL study. Ann Nucl Med. 2015;29:63–70. Undergoing pelvic lymphadenectomy leaves a woman at risk of chronic lymphoedema. Sentinel node mapping appears to be feasible and safe in women with early stage cervical cancer. Further studies are required to assess if it may be used to reduce pelvic lymph node dissection in selected cases.CrossRefPubMedPubMedCentral
32.
Zurück zum Zitat Van der Zee AG, Oonk MH, De Hullu JA, Ansink AC, Vergote I, Verheijen RH, et al. Sentinel node dissection is safe in the treatment of early-stage vulvar cancer. J Clin Oncol. 2008;26:884–9.CrossRefPubMed Van der Zee AG, Oonk MH, De Hullu JA, Ansink AC, Vergote I, Verheijen RH, et al. Sentinel node dissection is safe in the treatment of early-stage vulvar cancer. J Clin Oncol. 2008;26:884–9.CrossRefPubMed
33.
Zurück zum Zitat Baalbergen A, Veenstra Y, Stalpers L. Primary surgery versus primary radiotherapy with or without chemotherapy for early adenocarcinoma of the uterine cervix. Cochrane Database Syst Rev. 2013;1:CD006248. doi:10.1002/14651858.CD006248.pub3.PubMed Baalbergen A, Veenstra Y, Stalpers L. Primary surgery versus primary radiotherapy with or without chemotherapy for early adenocarcinoma of the uterine cervix. Cochrane Database Syst Rev. 2013;1:CD006248. doi:10.​1002/​14651858.​CD006248.​pub3.PubMed
34.
Zurück zum Zitat Selman TJ, Mann C, Zamora J, Appleyard TL, Khan K. Diagnostic accuracy of tests for lymph node status in primary cervical cancer: a systematic review and meta-analysis. Can Med Assoc J. 2008;178(7):855–62.CrossRef Selman TJ, Mann C, Zamora J, Appleyard TL, Khan K. Diagnostic accuracy of tests for lymph node status in primary cervical cancer: a systematic review and meta-analysis. Can Med Assoc J. 2008;178(7):855–62.CrossRef
36.
Zurück zum Zitat Robova H, Halaska MJ, Pluta M, Skapa P, Matecha J, Lisy J, et al. Oncological and pregnancy outcomes after high-dose density neoadjuvant chemotherapy and fertility-sparing surgery in cervical cancer. Gynecol Oncol. 2014;135:213–6.CrossRefPubMed Robova H, Halaska MJ, Pluta M, Skapa P, Matecha J, Lisy J, et al. Oncological and pregnancy outcomes after high-dose density neoadjuvant chemotherapy and fertility-sparing surgery in cervical cancer. Gynecol Oncol. 2014;135:213–6.CrossRefPubMed
37.
Zurück zum Zitat Bergmark K, Åvall‐Lundqvist E, Dickman PW, Henningsohn L, Steineck G. Lymphedema and bladder‐emptying difficulties after radical hysterectomy for early cervical cancer and among population controls. Int J Gynecol Cancer. 2006;16(3):1130–9.CrossRefPubMed Bergmark K, Åvall‐Lundqvist E, Dickman PW, Henningsohn L, Steineck G. Lymphedema and bladder‐emptying difficulties after radical hysterectomy for early cervical cancer and among population controls. Int J Gynecol Cancer. 2006;16(3):1130–9.CrossRefPubMed
Metadaten
Titel
Can We Be Less Radical with Surgery for Early Cervical Cancer?
verfasst von
Madeleine C. Macdonald
John A. Tidy
Publikationsdatum
01.03.2016
Verlag
Springer US
Erschienen in
Current Oncology Reports / Ausgabe 3/2016
Print ISSN: 1523-3790
Elektronische ISSN: 1534-6269
DOI
https://doi.org/10.1007/s11912-016-0501-5

Bessere Prognose mit links- statt rechtsseitigem Kolon-Ca.

06.05.2024 Kolonkarzinom Nachrichten

Menschen mit linksseitigem Kolonkarzinom leben im Mittel zweieinhalb Jahre länger als solche mit rechtsseitigem Tumor. Auch aktuell ist das Sterberisiko bei linksseitigen Tumoren US-Daten zufolge etwa um 11% geringer als bei rechtsseitigen.

Nodal-negativ nach neoadjuvanter Chemo: Axilladissektion verzichtbar?

03.05.2024 Mammakarzinom Nachrichten

Wenn bei Mammakarzinomen durch eine neoadjuvante Chemotherapie ein Downstaging von nodal-positiv zu nodal-negativ gelingt, scheint es auch ohne Axilladissektion nur selten zu axillären Rezidiven zu kommen.

Wo hapert es noch bei der Umsetzung der POMGAT-Leitlinie?

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Bestrahlung nach Prostatektomie: mehr Schaden als Nutzen?

02.05.2024 Prostatakarzinom Nachrichten

Eine adjuvante Radiotherapie nach radikaler Prostata-Op. bringt den Betroffenen wahrscheinlich keinen Vorteil. Im Gegenteil: Durch die Bestrahlung steigt offenbar das Risiko für Harn- und Stuhlinkontinenz.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.